isabelobrien, Author at European Medical Journal - Page 59 of 68

Boosting pharma sales rep’s virtual confidence

During the COVID-19 pandemic, pharmaceutical sales reps have been forced to navigate the virtual playing field, and as they operate in this new territory, their confidence is wavering.

The gender health gap

How can pharma better engage with male patients and encourage them to become more proactive when it comes to looking after their own health?

Talking to Karen Moyse

Karen Moyse, Founder and Managing Director, KineticFuture Leadership, discusses best practices for managing conflicting personalities.

Talking to Isma Benattia

Isma Benattia, Vice President Europe Medical Affairs, Amgen talks about harnessing technology to unlock better outcomes for patients.

Talking to Arun Mahtani

Arun Mahtani, Former Vice President, Channels Strategy and Digital Content, Teva Pharmaceuticals, talks about impactful patient initiatives.

Talking to Kumaran Krishnan

Kumaran Krishnan, Director, Medical Excellence and Digital Transformation, Teva, discusses unlocking further potential in developed markets.

Talking to Pierre Bourdage

Pierre Bourdage, Global Head Biopharmaceuticals, Sandoz, provides insight into the state and future of the biosimilars market.

Joining forces with the NHS

With a focus on open channels of communication, pharma and the NHS have the potential not just to survive, but to truly thrive.

The road to representative trial recruitment

Achieving equal and accurate representation in clinical trials has long been a challenge for the pharmaceutical industry. We have made great progress towards the goal of patient inclusivity, but what more can be done to ensure that all patient groups are adequately represented and how can digital help to achieve this?

Pfizer's Mace Rothenberg on his passion for advancing oncology

Mace Rothenberg, Chief Medical Officer, Pfizer, speaks to us about his sustained passion for advancing the field of oncology, the importance of diverse representation in patient groups, and the challenges of balancing lifespan with health span.